The liquid handling systems market is expected to reach USD 3.74 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 7.2%.

The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%.

The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period.

The global protein binding assays market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7%.

The cell viability assays market is expected to reach USD 4.16 billion by 2023 from an estimated USD 2.78 billion in 2018.

The market for surgical snare is expected to grow from USD 992 million in 2018 to USD 1,255 million by 2023.

The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018.

The specimen retrieval systems market is expected to grow from USD 230 million in 2019 to USD 290 million by 2024.

The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2019, at a CAGR of 10.1%

The global NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2018, at a CAGR of 18.7% during the forecast period.

This market is exceeded USD 180 million in 2019 and is projected to be valued over USD 360 million by 2024, at a CAGR of 14.6%

The global ATP assays market size is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%.

The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4%

The global ablation technology market is estimated to be valued at USD 2.82 billion in 2016 and is expected to reach USD 4.73 billion by 2021

The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period.

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period.

This report studies the neurovascular devices/interventional neurology market over the forecast period of 2016 to 2021.

This market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1%.

The global healthcare cloud computing market size is projected to reach USD 51.9 billion by 2024, from an estimated USD 23.4 billion in 2019.

The global e-prescribing market is expected to reach USD 1,403.2 Million by 2021 from USD 546.5 Million in 2016, at a CAGR of 20.8% during the forecast period.

The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018.

Base year considered for the report is 2017 and the forecast period is 2018–2023.

The cell viability assays market is expected to reach USD 4.16 billion by 2023 from an estimated USD 2.78 billion in 2018, at a CAGR of 8.4%.

This report studies the antibody production market for the forecast period of 2016 to 2021.

This report studies the sample preparation market for the forecast period of 2016 to 2021.

The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%.

The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

The Medical Equipment Maintenance Market is expected to grow from USD 28.97 billion in 2018 to USD 47.49 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the protein assays market.

This study provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends in the global market.

This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and ROW.

The surgical imaging market is expected to reach USD 1.63 Billion by 2022 from an estimated USD 1.25 Billion in 2017, at a CAGR of 5.5%.

The liquid handling systems market is expected to reach USD 3.74 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 7.2%.

MarketsandMarkets: The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2%.

The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.

The global vascular access devices market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%.

The liquid handling systems market is expected to reach USD 3.74 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 7.2%.

The liquid handling systems market is expected to reach USD 3.74 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 7.2%.

This report provides a detailed overview of the major drivers, restraints, opportunities, and threats impacting the global PEGylated proteins market.

This report studies the global electroceuticals/bioelectric medicine market for the forecast period of 2016 to 2021.

The global market was valued at USD 2.82 billion in 2016 and is expected to reach USD 4.73 billion by 2021 at a CAGR of 10.9%.

the injectable drug delivery market to grow from USD 362.4 billion in 2016 to USD 624.5 billion by 2021, at a CAGR of 11.5%

The medical equipment repair market to grow from USD 28.97 billion in 2018 to USD 47.49 billion by 2023, at a CAGR 10.4%

The global air quality monitoring system market (AQMS) is expected to reach USD 6.0 billion by 2025 from USD 4.3 billion in 2019, at a CAGR of 5.6%.

The Medical Equipment Maintenance Market is expected to reach USD 74.1 billion by 2027 from USD 28.9 billion in 2018, at a CAGR of 10.4%

The global Intraoperative Imaging market is projected to reach USD 2.06 Billion by 2021 from USD 1.61 Billion in 2016, at a CAGR of 5.2% during the forecast period of 2016 to 2021.

The global vascular access devices market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%.

The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).

Base year considered for the report is 2017 and the forecast period is 2018–2023.

The global fill-finish manufacturing market is expected to reach USD 4.47 Billion by 2022 from USD 2.96 Billion in 2017, at a CAGR of 8.6% during the forecast period (2017–2022).